Property and Equipment, Net (Tables)

12 Months Ended

Dec. 28, 2024

Property, Plant and Equipment [Abstract]

Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over estimated useful lives as follows:


			Useful Lives
Buildings and building improvements			7 to 39 years
Computer equipment and software			2 to 12 years
Demonstration units			2 to 3 years
Furniture and office equipment			2 to 15 years
Leasehold improvements			Lesser of useful life or term of lease
Machinery, equipment and tooling			3 to 20 years
Operating lease assets			Lesser of useful life or term of lease
Transportation, vehicles and other			1 to 20 years

Property and equipment, net, consists of the following:


(in millions)	December 28, 2024		December 30, 2023
Machinery, equipment and tooling	$	180.2	$	169.7
Building and building improvements	150.3		151.0
Operating lease assets	148.6		92.2
Land(1)	54.3		66.2
Computer equipment and software	44.4		45.5
Leasehold improvements	40.8		37.5
Construction-in-progress (CIP)(2)	30.6		59.2
Furniture and office equipment	17.5		20.4
Demonstration units	10.9		11.1
Transportation, vehicles and other(3)(4)	0.2		34.0
Total property and equipment	677.8		686.8
Accumulated depreciation	(296.2)		(262.4)
Property and equipment, net	$	381.6	$	424.4

______________

(1) At March 30, 2024, property, plant and equipment, net, excluded $11.4 million of idle undeveloped land held outside of the U.S., which was classified as held for sale within the healthcare segment. In May 2024, the Company completed the sale of the land, resulting in a gain of $0.9 million, which was recorded net of transaction costs, foreign currency translation and cumulative translation adjustment.

(2) In December 2024, in connection with the strategic realignment initiative, the Company recorded a charge of approximately $16.0 million related to a reduction of capitalized costs included in the CIP balance for the property in Vancouver, British Columbia, which was recorded to selling, general and administrative expenses.

(3) During the three months ended September 28, 2024, the Company reduced its fleet of vehicles for use primarily by field sales representatives. The proceeds from the sale of the vehicles were $2.0 million.

(4) In October 2024, the Company grounded the corporate aircraft and started exploring disposition strategies. In December 2024, the Company entered into an letter of intent to sell the aircraft, and classified the asset as held for sale within the healthcare segment as of December 28, 2024. On January 29, 2025, the Company completed the sale of the corporate aircraft for $19.5 million.